Open Access Editorial

Could Netarsudil be the promising treatment of Glaucoma?

Mina Abdelmseih*

Department of Fulda Eye Clinic, Germany

Corresponding Author

Received Date: March 04, 2019;  Published Date: March 12, 2019


Glaucoma is a group of chronic optic neuropathies characterized by degenerative changes in the optic nerve and visual field loss [1]. Intraocular pressure is considered the major risk factor for the progression of glaucomatous optic neuropathy involving the death of retinal ganglion cells and their axons [2].

Signup for Newsletter
Scroll to Top